PROVIDER PROFILE · NPI 1689768475
Partow KebriaeiM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
133
Unique beneficiaries
—
Total services
619
Distinct HCPCS
4
Medicare payment
$62K
Peer benchmark
Total Medicare services vs. 19 Hematopoietic Cell Transplantation and Cellular Therapy providers in TX — top quintile (cohort median 519).
PRESCRIBING · PART D · 2024
Total Rx claims
91
Beneficiaries
—
Total drug cost
$123K
Distinct drugs
6
Brand share
62.6%
Top prescribed drugs
Posaconazole20 claims
Valacyclovir Hcl18 claims
Pantoprazole Sodium14 claims
Letermovir13 claims
Sulfamethoxazole/Trimethoprim13 claims
QUALITY · MIPS · 2024
Final MIPS score
84.3
Quality
70.8
Cost
67.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
6
By payment type
Consulting Fee$2K
Food and Beverage$157
Top paying entities
Consulting Fee$2K
Food and Beverage$157
REFERRAL NETWORK
Where Partow Kebriaei's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER | 52 | 1,390 |
| TARRAND, JEFFREY | 13 | 69 |
| Cheng Yin Pathology · Houston, TX | 11 | 41 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE